ALNYLAM PHARMACEUTICALS INC (ALNY)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About ALNYLAM PHARMACEUTICALS INC
Alnylam Pharmaceuticals, Inc. develops RNA interference medicines in biotechnology and markets treatments for rare diseases, with $3.7 billion in revenue in FY2025. Listed on NASDAQ as ALNY, the company sells ONPATTRO for polyneuropathy associated with hereditary transthyretin-mediated amyloidosis, GIVLAARI for acute hepatic porphyria, and OXLUMO for primary hyperoxaluria type 1.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
ALNYLAM PHARMACEUTICALS INC's Technical Indicators Summary
ALNY’s readings are consistent with a strong sell conclusion. The stock is trading well below its short, medium and long moving averages, including a much higher 200‑day reference, while momentum indicators and MACD are firmly negative. Trend strength indicators also favor the downside, and on‑balance volume is weak, indicating distribution. Average true range is elevated in percent terms which increases downside risk during moves lower, and the pivot sits close to the current level without offering support. Technical takeaway: Strong Sell.
| Indicator | Value |
|---|---|
RSI (14) | 33.59 |
Stochastic %K (14, 3, 3) | 21.15 |
CCI (20) | -78.71 |
WPR (14) | -79.34 |
Momentum (10) | -61.42 |
MFI | 46.16 |
MACD Level (12, 26) | -19.96 |
Bollinger Bands | $190.35 - $314.38 |
ATR (14) | $15.22 (7.01%) |
ADX (14) | 25.14 |
OBV | 2,322,411 |
Classic Pivot Point | $216.44 |
Fibonacci Pivot Point | $216.44 |
Simple Moving Averages | $230.64 - $341.55(5 indicators) |
Exponential Moving Averages | $230.40 - $342.63(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
ALNY finished the last trading session with a tiny decline, closing -1.01% beneath the prior close of 219.20. ALNY is drawing heightened options interest, with V/OI ratio at 115.4, per Moomoo.
Trading Volume
Below 10d avg (3.2M)
1.4M
vs S&P 500 Today
Underperforming Market
-0.95%
52-Week Position
Near lows
6.4%
Updated: August 11, 2026 at 12:25 UTC
Quote Summary
ALNY Headlines
ClearBridge Shifts Amid Growth Stock Turmoil
April 9, 2026